Optimark and Catapres-tts-1 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Optimark (gadoversetamide) and Catapres-tts-1 (clonidine). Common drug interactions include nephrogenic systemic fibrosis among females.

The phase IV clinical study analyzes what interactions people have when they take Optimark and Catapres-tts-1. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Optimark?

Optimark has active ingredients of gadoversetamide. eHealthMe is studying from 3,055 Optimark users. Check the latest studies of Optimark.

What is Catapres-tts-1?

Catapres-tts-1 has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 2,047 Catapres-tts-1 users. Check the latest studies of Catapres-tts-1.

On Jul, 12, 2026

11 people who take Optimark and Catapres-tts-1 together, and have interactions are studied.

Optimark and Catapres-tts-1 drug interactions.

What are the common drug interactions of Optimark and Catapres-Tts-1, by gender? *:

female:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Pneumonia
Urinary tract infection
Vomiting
Fluid retention (an abnormal accumulation of fluid in the blood)
Gait disturbance
Rash
Skin hypopigmentation (loss of skin colour)
Skin plaque (red, scaly patches to appear on the skin)

male:

n/a

What are the common drug interactions of Optimark and Catapres-Tts-1, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Constipation
Decreased appetite
Diarrhoea
Dizziness
Excoriation (to tear or wear off the skin of)
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Hypotension (abnormally low blood pressure)
Insomnia (sleeplessness)
Lethargy (tiredness)

50-59:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Dry skin
Emotional distress
Erythema (redness of the skin)
Excoriation (to tear or wear off the skin of)
Gait disturbance
Injury
Joint range of motion decreased (disease of joint movement)
Joint stiffness

60+:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Dry skin
Skin plaque (red, scaly patches to appear on the skin)
Skin tightness
Swelling
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Chest pain
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Encephalomalacia (localized softening of the brain substance, due to haemorrhage or inflammation)

What are the existing conditions these people have? *

Vaginal Infection: 2 people, 18.18%
Stress And Anxiety: 2 people, 18.18%
Nuclear Magnetic Resonance Imaging Brain: 2 people, 18.18%
Nuclear Magnetic Resonance Imaging Abdominal: 2 people, 18.18%
Blood Phosphorus Increased: 2 people, 18.18%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 9.09%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Optimark and Catapres-tts-1?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously